MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
MiMedx Group Operating Income 2011-2026 | MDXG
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income MiMedx Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.9 M | 58.9 M | 37.1 M | -14.7 M | -7.05 M | -45.4 M | -21.2 M | -3.92 M | 46.2 M | 884 K | 24.4 M | 7.1 M | -2.64 M | -5.36 M | -9.76 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 63.9 M | -45.4 M | 8.56 M |
Quarterly Operating Income MiMedx Group
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.4 M | 8.25 M | - | 11.2 M | 23.4 M | 13.2 M | - | 11.1 M | 10.8 M | -340 K | - | -7.1 M | -9.64 M | -9.3 M | - | -1.08 M | -410 K | -6.85 M | - | -9.71 M | -5.86 M | -13.7 M | - | 14.2 M | -17.1 M | -13.4 M | - | 373 K | 1.68 M | 2.97 M | - | 8.84 M | 7.21 M | 6.18 M | - | 4.7 M | 3.56 M | 1.47 M | - | 6.71 M | 5.65 M | 4.25 M | - | 3.73 M | -392 K | -891 K | - | -256 K | -744 K | -227 K | - | -3.63 M | -118 K | -631 K | - | -1.65 M | -2.42 M | -3.26 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 23.4 M | -17.1 M | 1.21 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
-7.85 M | $ 32.81 | 5.87 % | $ 1.51 B |  USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 12.36 | 3.48 % | $ 1.67 B | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 9.39 | 3.53 % | $ 266 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 38.22 | 4.23 % | $ 5.7 K | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 24.45 | 2.8 % | $ 207 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.61 | 0.13 % | $ 122 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-19.8 M | $ 3.38 | -0.59 % | $ 127 M |  France |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
608 M | $ 178.65 | 7.06 % | $ 13.4 B | USA |
 |
Globus Medical
GMED
|
480 M | $ 91.76 | 1.91 % | $ 12.4 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.2 | 3.33 % | $ 889 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.91 | 4.37 % | $ 1.16 M | USA |
 |
Nevro Corp.
NVRO
|
-126 M | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.64 | 4.94 % | $ 39.8 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 9.69 | 3.86 % | $ 746 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 9.87 | 2.02 % | $ 354 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 62.67 | 1.33 % | $ 92.8 B | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 11.53 | 4.49 % | $ 1.73 B | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.14 | 10.19 % | $ 19.3 M | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 36.63 | 5.96 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 87.27 | 2.49 % | $ 3.03 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 16.33 | 3.62 % | $ 383 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 82.18 | 1.68 % | $ 48.1 B | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 53.86 | -1.01 % | $ 1.58 B | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 64.88 | 2.11 % | $ 3.54 B |  Britain |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.7 | 1.24 % | $ 68.2 M | USA |